You have 9 free searches left this month | for more free features.

Takayasu Arteritis

Showing 1 - 25 of 149

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Takayasu Arteritis Complicated With Pulmonary Artery Involvement

Recruiting
  • Takayasu Arteritis With Pulmonary Artery Involvement
  • +2 more
  • Percutaneous transluminal pulmonary angioplasty
  • Beijing, China
    Fuwai Hospital, National Center for Cardiovascular Diseases, Chi
Jan 9, 2023

Takayasu Arteritis Trial in Beijing (Tofacitinib 5 MG, Prednisolone, Placebo of tofacitinib 5mg)

Recruiting
  • Takayasu Arteritis
  • Tofacitinib 5 MG
  • +3 more
  • Beijing, China
    Peking Union Medical College Hospital
Feb 19, 2023

PET Imaging of Giant Cell and Takayasu Arteritis

Active, not recruiting
  • Giant Cell Arteritis
  • Takayasu Arteritis
  • PET-MRI
  • Cambridge, Cambridgeshire, United Kingdom
  • +1 more
Jul 31, 2022

Takayasu Arteritis Trial in China (Leflunomide 10mg Tab, Prednisone Acetate, Placebos)

Recruiting
  • Takayasu Arteritis
  • Leflunomide 10mg Tab
  • +2 more
  • Beijing, Beijing, China
  • +6 more
Jun 25, 2022

Takayasu Arteritis Trial in Paris (UltraFast ultrasound)

Completed
  • Takayasu Arteritis
  • UltraFast ultrasound
  • Paris, France
    Hôpital Européen Georges Pompidou
Mar 22, 2022

Armenian NAtionwide REGistry of Systemic Autoimmune and

Not yet recruiting
  • Behcet Disease
  • +8 more
  • Usual medical management of patients, blood and stool samples for biobanking
  • Yerevan, Armenia
  • +1 more
Jun 13, 2023

Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis

Recruiting
  • Takayasu's Arteritis
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Takayasu Arteritis Trial in Beijing (Adalimumab Injection, Tofacitinib 5 MG)

    Recruiting
    • Takayasu Arteritis
    • Adalimumab Injection
    • Tofacitinib 5 MG
    • Beijing, China
    • +3 more
    Feb 26, 2022

    Individuals With Takayasu's Arteritis

    Completed
    • Takayasu's Arteritis
      • Boston, Massachusetts
      • +8 more
      Jul 11, 2022

      Takayasu Arteritis Trial in Shanghai (Tofacitinib, Methotrexate)

      Recruiting
      • Takayasu Arteritis
      • Shanghai, Shanghai, China
        Lindi Jiang
      Oct 19, 2021

      Takayasu Arteritis Trial in China (MMF, CYC, Glucocorticoids)

      Active, not recruiting
      • Takayasu Arteritis
      • Shijiazhuang, Hebei, China
      • +6 more
      Feb 26, 2022

      Takayasu Arteritis Trial in Japan (Ustekinumab, Placebo, Glucorticoid Taper Regimen)

      Recruiting
      • Takayasu Arteritis
      • Bunkyo-Ku, Japan
      • +28 more
      Aug 16, 2022

      Takayasu Arteritis, Tocilizumab, Adalimumab Trial in Shanghai (Tocilizumab, Adalimumab)

      Recruiting
      • Takayasu Arteritis
      • +3 more
      • Tocilizumab
      • Adalimumab
      • Shanghai, Shanghai, China
        Department of Rheumatology in Zhongshan hospital, Fudan Universi
      Aug 7, 2021

      The Registry Study of Takayasu Arteritis in East China

      Recruiting
      • Takayasu Arteritis
      • +4 more
      • Shanghai, Shanghai, China
        Department of Rheumatology in Zhongshan hospital, Fudan Universi
      Aug 7, 2021

      Physical Activity, Takayasu Arteritis Trial in Sao Paulo (Combined acute physical exercises (strength and aerobic))

      Completed
      • Physical Activity
      • Takayasu Arteritis
      • Combined acute physical exercises (strength and aerobic)
      • Sao Paulo, Brazil
        Samuel Katsuyuki Shinjo
      Apr 29, 2021

      Giant Cell Arteritis, Takayasu Arteritis, Cogan Syndrome Trial in Cambridge, Glasgow, London (Rituximab, Infliximab,

      Recruiting
      • Giant Cell Arteritis
      • +8 more
      • Rituximab
      • +2 more
      • Cambridge, United Kingdom
      • +2 more
      Dec 9, 2021

      Eosinophilic Granulomatosis With Polyangiitis (EGPA), Churg-Strauss Syndrome (CSS), Giant Cell Arteritis Trial in United States

      Recruiting
      • Eosinophilic Granulomatosis With Polyangiitis (EGPA)
      • +6 more
      • Naltrexone Hydrochloride
      • Placebo Comparator
      • Boston, Massachusetts
      • +6 more
      Jan 25, 2022

      One-Time DNA Study for Vasculitis

      Recruiting
      • Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)
      • +5 more
        • Los Angeles, California
        • +13 more
        May 16, 2022

        Takayasu Arteritis (TAK) Trial in Worldwide (Upadacitinib, Placebo for Upadacitinib, Prednisolone)

        Recruiting
        • Takayasu Arteritis (TAK)
        • Salvador, Bahia, Brazil
        • +44 more
        Aug 22, 2022

        VCRC Tissue Repository

        Recruiting
        • Aortitis
        • +10 more
          • Boston, Massachusetts
          • +7 more
          Jan 25, 2022

          Takayasu Arteritis Trial (Infliximab, Tocilizumab)

          Not yet recruiting
          • Takayasu Arteritis
          • (no location specified)
          Sep 21, 2020

          TAKAYASU ARTERITIS Trial in Saint-Antoine (Tocilizumab)

          Completed
          • TAKAYASU ARTERITIS
          • Saint-Antoine, Paris, France
            Department of internal medicine
          Aug 17, 2020

          Wegeners Granulomatosis (Granulomatosis With Polyangiitis), Microscopic Polyangiitis, Churg Strauss Syndrome (Eosinophilic

          Recruiting
          • Wegeners Granulomatosis (Granulomatosis With Polyangiitis)
          • +6 more
            • San Francisco, California
            • +37 more
            Nov 4, 2022

            Takayasu Arteritis, Methotrexate, Inhibition Trial in Shanghai (Methotrexate Tablets, Tofacitinib tablet)

            Recruiting
            • Takayasu Arteritis
            • +3 more
            • Methotrexate Tablets
            • Tofacitinib tablet
            • Shanghai, China
              Lindi Jiang
            Jun 10, 2020

            Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity

            Completed
            • SCAD
            • +28 more
              • Rochester, Minnesota
                Mayo Clinic
              Nov 20, 2020